TradingBanker

Aurobindo Pharma: a probable long trade

看多
NSE:AUROPHARMA   AUROBINDO PHARMA
Aurobindo Pharma previously took support from support zone and 200 EMA (blue line).
FII increased their stake during the 2nd quarter as well.

Accumulate with a SL of 318 WCLBS.

Final target new ATH

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。